KH Neochem (4189) FY2026 Q2 Earnings Report

Quick View

Executive Summary

The defining feature of the quarter was an increase in profit despite declining revenue, driven by a significant improvement in profitability. Revenue declined to ¥533.0B (¥587.5B in the same period last year, YoY -9.3%), while Operating Income increased to ¥75.0B (¥60.1B last year, YoY +24.9%), Ordinary Income to ¥74.5B (¥57.6B last year, YoY +29.3%), and Net Income to ¥53.6B (¥39.9B last year, YoY +34.4%). The primary factor behind the increase in profit was the decline in the cost-of-sales ratio to 73.6% (78.5% last year), which improved the gross profit margin by +4.9pt to 26.4% (21.5% last year); SG&A expenses were held broadly in line with the previous year. In addition, lower non-operating losses and a decline in the effective tax rate resulted in progressively higher growth rates for Operating Income, Ordinary Income, and Net Income, respectively.

Factors Affecting Performance

【Revenue】Revenue was ¥533.0B, representing a year-on-year decline of -9.3%. Although segment-level disclosure was not provided, cost of sales declined by 15.0% year on year to ¥392.3B, outpacing the decline in revenue. This suggests that, in addition to lower sales volume, changes in product mix and pricing contributed to the reduction in cost of sales.

【Profit and Loss】The cost-of-sales ratio declined by -4.9pt from 78.5% to 73.6%, while the gross profit margin improved to 26.4% (21.5% last year). SG&A expenses were ¥65.7B, broadly flat year on year (-0.7%), but the SG&A ratio increased by +1.1pt to 12.3% (11.3% last year) due to the decline in revenue. As the improvement in the gross profit margin exceeded the increase in the SG&A ratio, the Operating Income margin expanded by +3.9pt to 14.1% (10.2% last year), and Operating Income increased to ¥75.0B (YoY +24.9%). In non-operating items, non-operating income of ¥4.0B and expenses of ¥4.5B resulted in a net burden of only -¥0.5B, narrowing from -¥2.5B in the previous year. This caused the growth rate of Ordinary Income (+29.3%) to exceed that of Operating Income (+24.9%). Furthermore, the effective tax rate declined from 30.8% to 28.1%, resulting in Net Income of ¥53.6B (YoY +34.4%) and a further expansion in the growth rate. Overall, the company achieved higher profit despite lower revenue, with improvements in its cost structure and cost discipline supporting earnings growth during a period of declining revenue.

Key Financial Indicators

【Profitability】ROE was 6.9% (Net Income of ¥53.6B ÷ ending shareholders’ equity of ¥776.4B). Both the Operating Income margin of 14.1% and the Net Income margin of 10.1% (6.8% last year) improved from the previous year. The core driver of the improvement in profitability was the increase in the gross profit margin to 26.4% (21.5% last year), led by the decline in the cost-of-sales ratio.【Cash Quality】Operating Cash Flow (OCF) was ¥78.1B, approximately 1.46 times Net Income of ¥53.6B, indicating strong cash-generation capacity supporting reported earnings. However, OCF was approximately 74% of EBITDA of ¥104.9B (Operating Income of ¥75.0B + depreciation and amortization of ¥29.9B), as working-capital headwinds such as an increase in inventories (-¥12.2B) and a decrease in trade payables (-¥37.4B) somewhat constrained cash conversion.【Investment Efficiency】Total asset turnover was approximately 0.41x (Revenue of ¥533.0B ÷ average total assets of ¥1311.1B). Capital expenditures of ¥29.0B were approximately equal to depreciation and amortization of ¥29.9B (CapEx/depreciation and amortization of 0.97x), indicating that capital allocation was primarily focused on replacement and maintenance investment.【Financial Soundness】The Equity Ratio improved to 58.8% (55.8% last year, +3.0pt). Cash and cash equivalents were ¥78.0B, and Operating Income coverage of interest expense of ¥1.1B was approximately 67x, indicating that the impact of interest costs was limited.

Cash Flow Analysis

OCF increased significantly by +35.1% year on year to ¥78.1B, representing high cash quality, with cash generation of approximately 1.46 times Net Income of ¥53.6B. The subtotal before changes in working capital was ¥93.7B, but an increase in inventories (-¥12.2B) and a decrease in trade payables (-¥37.4B) absorbed cash. After collection of trade receivables (+¥13.5B) and payment of corporate income taxes and other taxes (-¥16.3B), OCF settled at its final level. Investing Cash Flow was -¥29.5B, of which capital expenditures accounted for ¥29.0B, remaining at approximately the same level as depreciation and amortization of ¥29.9B and indicating maintenance and replacement investment. Financing Cash Flow was -¥37.9B and included dividend payments (-¥18.5B), adjustments to short-term funding, and share repurchases (-¥0.6B). Free Cash Flow, the sum of OCF and Investing Cash Flow, was ample at ¥48.6B, comfortably exceeding dividends and capital expenditures.

Quality of Earnings

The increase in profit for the period was not attributable to temporary non-operating factors, but was led by a structural, core-business improvement resulting from the lower cost-of-sales ratio. Non-operating income of ¥4.0B and non-operating expenses of ¥4.5B were both small, while equity-method investment income of ¥2.8B made a certain contribution to Ordinary Income. No temporary items corresponding to extraordinary gains or losses were identified. OCF reaching approximately 1.46 times Net Income indicates a low level of accruals (accounting estimation components), demonstrating strong cash support for reported earnings. However, comprehensive income was ¥68.8B, exceeding Net Income of ¥53.6B by +¥15.2B. The primary reason for this difference was an increase in valuation difference on securities of +¥15.3B. This should be noted as a non-recurring increase in net assets dependent on market fluctuations.

Earnings Forecast and Guidance

Progress against the full-year forecast was 46.8% for Revenue (¥533.0B/¥1140.0B), 55.6% for Operating Income (¥75.0B/¥135.0B), 59.1% for Ordinary Income (¥74.5B/¥126.0B), and 60.7% for Net Income attributable to owners of the parent (¥52.8B/¥87.0B). Progress on profit significantly exceeded progress on revenue, indicating that earnings were advancing ahead of schedule. The full-year forecast calls for increases of +20.0% in Operating Income and +16.7% in Ordinary Income, while Revenue is projected to decline modestly by -1.0%; first-half results are consistent with this earnings-growth scenario. No revision to the earnings forecast was made during the quarter, although the dividend forecast was revised.

Shareholder Returns

An interim dividend of ¥55 per share was paid, and the full-year dividend forecast is ¥130. The Payout Ratio against full-year forecast EPS of ¥248.45 is 52.3% (¥130/¥248.45), indicating a plan to distribute more than half of earnings to shareholders. Share repurchases were small at ¥0.6B, leaving shareholder returns primarily dividend-based. OCF and Free Cash Flow for the quarter comfortably exceeded the dividend burden (first-half actual payments of ¥18.5B), and no concerns regarding the funding source for shareholder returns are currently evident.

Risk Factors

1. Deterioration in working capital: Inventories were ¥204.6B, having increased by ¥12.2B during the first half, while trade payables declined by ¥37.4B. This partially offset the increase in OCF, and changes in inventory levels and trading terms could affect future cash-generation capacity.

2. Dependence on short-term funding: Short-term borrowings were ¥101.0B, exceeding cash and cash equivalents of ¥78.0B. Within the interest-bearing debt structure, which also includes bonds of ¥50.0B, the short-term component is relatively high. Attention to refinancing conditions will be necessary if market conditions change.

3. Market fluctuations in securities valuations: Investment securities were ¥110.0B, up +27.4% year on year, while valuation difference on securities also increased by +¥15.3B. Although these valuation gains are supporting net assets, they could work in the opposite direction due to fluctuations in market prices.

Industry Benchmark (For Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

Both the Operating Income margin and Net Income margin exceeded the industry median, indicating that profitability was relatively high within the industry.

Growth and Capital Efficiency

The Revenue growth rate was significantly below the industry median, indicating that the company was relatively less competitive within the industry during a period of top-line growth.

※Source: Compiled by the Company

Key Takeaways from the Earnings Results

1. Despite a -9.3% decline in Revenue, the Operating Income margin improved to 14.1% (10.2% last year), with gross-margin-led improvements in the cost structure generating higher profit despite lower revenue. Whether this improvement resulted from pricing and product-mix factors or temporary easing in raw-material market conditions will be a key point in assessing the sustainability of margins as revenue recovers.

2. Progress against the full-year forecast was ahead of schedule on the profit side, at 60.7% for Net Income and 55.6% for Operating Income, while progress on Revenue was somewhat slower at 46.8%. The trend in the second half toward the full-year Revenue forecast of -1.0% will therefore be a point of focus.

3. Increases in inventories and decreases in trade payables created working-capital headwinds against OCF growth of +35.1%. Although OCF itself was approximately 1.46 times Net Income and cash support was strong, trends in inventories and trade payables will be closely monitored as factors affecting future cash-conversion efficiency.

Theoretical Share Price (Reference Value)

This is a reference range mechanically calculated solely from publicly disclosed data using a residual income model (Ohlson-type model with an explicit five-year fade). It is not a forecast of the market share price or a recommendation of any specific investment action.

Sensitivity: ¥2,330–¥2,463 at ±1% for the cost of equity, and ¥2,391–¥2,401 at ±0.1 for ω.

Notes:

• Goodwill amortization of ¥3.8 per share is added back to earnings (for non-cash expenses and comparability with IFRS companies).
• Because Net Income progress against the full-year forecast (61%) exceeds the standard level (50%), forecast EPS is adjusted upward within a maximum range of +10% (because companies advancing ahead of schedule tend to exceed their forecasts; the adjustment may be excessive for businesses with strong seasonality).
• Net assets as of the quarter-end are used (there is a timing difference relative to the full-year forecast).
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual income model / Interest rate reference month: 2026-06 / This value does not forecast or guarantee the future share price)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmark is reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, consulting a professional as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

KH Neochem delivered a strong profit-led FY2026 Q2 despite a 9.3% year-on-year decline in revenue. Revenue was ¥53.30bn, while operating income rose 24.9% to ¥7.50bn. Ordinary income increased 29.3% to ¥7.45bn and profit attributable to owners increased 34.3% to ¥5.28bn. Gross profit expanded to ¥14.07bn from ¥12.62bn in the prior-year period. The gross margin improved by 490bp to 26.4%, indicating a substantial improvement in the spread between selling prices and production costs. Operating margin expanded by 385bp to 14.1% from 10.2%, placing profitability near the upper end of the stated good-to-excellent benchmark range. Net margin rose by 321bp to 9.9% from 6.7%, supported by the operating improvement and limited financing costs. SG&A expense declined 0.7% year on year to ¥6.57bn while sales declined 9.3%, demonstrating favorable operating leverage. EBITDA increased to ¥10.49bn and the EBITDA margin reached 19.7%. Operating cash flow of ¥7.81bn exceeded net income of ¥5.28bn, supporting the underlying cash quality of reported earnings. Free cash flow was a positive ¥4.86bn after ¥2.90bn of capital expenditure. Nevertheless, the manufacturing working-capital cycle remains the principal operational concern, with reported DSO of 108 days, reported inventory days of 119 days and 95 days in separate alerts, and a 140-day cash conversion cycle. The full-year plan implies that management expects sales to remain modestly below the prior year while operating income rises 20.0%, making sustained margin discipline more important than volume recovery. Q2 progress against full-year operating income guidance is ahead of the normal halfway pace, whereas revenue progress is slightly below it. The company revised its dividend, and the planned full-year DPS of ¥130 suggests continued shareholder distributions backed by current earnings and cash generation. Overall, the result reflects materially improved profitability and sound near-term solvency, offset by elevated working-capital intensity and the refinancing dependence associated with exclusively short-term reported debt.

Profitability Analysis

Reported annualized ROE is 13.6%, comprising a 9.9% net profit margin, 0.807x asset turnover, and 1.70x financial leverage. The margin component is the major strength: EBIT margin reached 14.1%, up 385bp year on year, while net margin rose to 9.9% from 6.7%. Gross margin increased by 490bp to 26.4%, showing that the ¥7.84bn decline in cost of sales exceeded the ¥5.46bn reduction in revenue. SG&A fell to ¥6.57bn from ¥6.62bn, so cost discipline amplified the gross-profit recovery rather than offsetting it. This is a favorable operating-leverage outcome because SG&A did not grow faster than revenue. The 1.70x leverage factor is moderate rather than aggressive, and the 0.993 interest burden confirms that interest costs have little effect on earnings. The 0.709 tax burden and 28.1% effective tax rate are broadly normal, leaving profit conversion from pre-tax income intact. EBITDA was ¥10.49bn, or a 19.7% margin, and JGAAP goodwill amortization was only ¥0.67bn, equivalent to less than 1% of EBITDA; therefore, JGAAP goodwill accounting is not materially depressing comparability. The key sustainability test is whether pricing, product mix, and input-cost conditions can preserve the current 26.4% gross margin as sales remain below the prior-year level.

Growth Assessment

Top-line momentum remains weak, with H1 revenue down 9.3% year on year to ¥53.30bn. However, operating income growth of 24.9% and owner-attributable profit growth of 34.3% show that earnings growth is currently driven by margin recovery rather than sales expansion. Gross profit increased 11.5% year on year despite lower revenue, which indicates a sharp improvement in unit economics. The FY2026 plan calls for revenue of ¥114.00bn, down 1.0% year on year, operating income of ¥13.50bn, up 20.0%, and ordinary income of ¥12.60bn, up 16.7%. H1 sales progress is 46.8% of the full-year target, 3.2 percentage points below the standard 50% halfway pace. Operating-income progress is 55.6%, 5.6 percentage points ahead of the standard pace, while ordinary-income progress is 59.1%, 9.1 points ahead. Owner-attributable profit progress is 60.7% of the ¥8.70bn forecast, indicating that the plan embeds a lower second-half profit run-rate than achieved in H1. This provides some execution cushion, but also means investors should monitor whether the revenue shortfall persists and whether margins normalize in the second half. Capital expenditure of ¥2.90bn was broadly matched to depreciation and amortization of ¥2.99bn, with a 0.97x CapEx/depreciation ratio consistent with maintenance and selective replacement rather than a major capacity expansion phase.

Financial Health

Liquidity is sound, with a 159.9% current ratio, a 110.5% quick ratio, and working capital of ¥24.82bn. Current assets of ¥66.27bn exceed current liabilities of ¥41.45bn, mitigating near-term maturity mismatch risk at the aggregate balance-sheet level. Solvency metrics are also conservative: reported debt-to-equity is 0.70x, debt-to-capital is 11.5%, and debt/EBITDA is 0.96x. Interest coverage is exceptionally strong at 66.97x on an EBIT basis and 93.66x on an EBITDA basis. The reported short-term debt ratio is 100%, which is a refinancing-risk alert because the company relies on short-dated funding rather than terming out reported borrowings. Cash and deposits of ¥7.80bn cover 0.77x of reported short-term debt, so cash alone does not fully repay the short-term funding balance. This refinancing exposure is currently manageable because of the substantial working-capital buffer, low debt/EBITDA, and strong interest coverage, but it increases sensitivity to funding-market conditions and bank rollover availability. Total equity increased to ¥77.64bn from ¥72.63bn year on year, and the equity ratio improved to 56.5% from 53.6%. Investment securities increased by ¥2.36bn, or 27.4%, to ¥11.00bn and now account for 8.3% of total assets; this adds market-value and unrealized-gain/loss sensitivity to equity and comprehensive income. Goodwill is only ¥0.64bn, equal to 0.8% of equity and 0.06x EBITDA, so acquisition-related impairment risk is immaterial. Net defined-benefit liability was ¥2.29bn and represents a manageable long-term obligation.

Notable B/S Changes

Investment securities: +¥2.36bn (+27.4%) to ¥11.00bn - increased exposure to market-price movements and OCI volatility; the balance equals 8.3% of total assets. Total equity: +¥5.33bn (+7.1%) to ¥77.64bn - earnings retention and positive comprehensive income strengthened capitalization, with the equity ratio improving to 56.5% from 53.6%. Trade payables: -¥3.67bn (-16.4%) to ¥18.72bn - lower supplier financing contributed to working-capital cash absorption and should be monitored alongside the extended cash conversion cycle.

Cash Flow Quality

Cash-flow quality is favorable at the earnings level: operating cash flow was ¥7.81bn, equal to 1.48x owner-attributable net income of ¥5.28bn and well above the 0.8x quality-warning threshold. Free cash flow was ¥4.86bn after ¥2.90bn of capital expenditure, leaving positive internally generated funding for dividends and modest repurchases. The accruals ratio was negative 1.9%, which supports cash-backed earnings rather than aggressive accrual recognition. Cash conversion from EBITDA was 0.74x, below the 0.9x excellent benchmark but above the 0.7x concern threshold, indicating reasonable but not fully optimized EBITDA-to-cash conversion. Working-capital movements remain material: inventories increased by ¥1.22bn, trade payables declined by ¥3.74bn, and other current assets increased by ¥2.11bn, each absorbing cash. Trade receivables declined by ¥1.35bn and partially offset these uses of cash. The reported DSO of 108 days is a high-receivable-days alert; it indicates a long collection cycle, ties up capital, and may increase sensitivity to customer payment behavior. The reported inventory-day alerts of 119 days and 95 days both exceed the relevant warning thresholds, signaling elevated stockholding, potential demand-mix imbalance, and inventory valuation or obsolescence risk in a chemical-manufacturing context. The reported 140-day cash conversion cycle is also a high-risk alert because it combines slow collections and heavy inventory investment into a prolonged cash recovery period. These working-capital characteristics are not negated by the strong H1 operating cash flow, but they make future cash generation more sensitive to sales volumes, product demand, and supplier-credit conditions.

Dividend Sustainability

The company paid an interim DPS of ¥55 and forecasts full-year DPS of ¥130, implying a ¥75 year-end dividend. Based on forecast EPS of ¥248.45, the prospective full-year dividend payout ratio is approximately 52.3%, below the 60% sustainability benchmark. The reported H1 payout ratio is 38.7%, based on the interim dividend relative to H1 earnings. H1 free cash flow of ¥4.86bn covers the interim dividend cash requirement of approximately ¥1.93bn by about 2.5x. On a simple comparison of H1 free cash flow with the planned full-year dividend cash requirement of approximately ¥4.55bn, coverage is about 1.1x, indicating limited but positive headroom before considering second-half cash generation. Share repurchases were limited to ¥0.06bn in H1; therefore, shareholder-return demands are principally dividend-based rather than buyback-led. The dividend revision signals management confidence, but continuation of the ¥130 DPS requires sustained operating margins and disciplined working-capital management, particularly given the longer cash conversion cycle.

Risk Assessment

Business risks include Demand and pricing risk: revenue declined 9.3% year on year, so the current earnings recovery relies primarily on gross-margin expansion rather than volume growth., Chemical-manufacturing input-cost and energy-cost risk: the 490bp gross-margin improvement could reverse if feedstock, energy, or selling-price conditions become less favorable., Inventory risk: reported inventory-day alerts of 119 days and 95 days both indicate elevated stockholding, increasing exposure to demand shortfalls, product-mix changes, and valuation pressure., Customer-collection risk: a reported DSO of 108 days is above the 60-day warning level and extends exposure to customer credit conditions., Working-capital efficiency risk: the reported 140-day cash conversion cycle can constrain cash generation during periods of lower sales or tighter supplier-credit terms..

Financial risks include Refinancing risk: the 100% reported short-term debt ratio means funding must be rolled over regularly; this is the root cause of the refinancing-risk alert., Liquidity sensitivity: cash covers 0.77x of reported short-term debt, although current and quick ratios remain healthy at 159.9% and 110.5%, respectively., Investment-security valuation risk: investment securities rose ¥2.36bn year on year to ¥11.00bn, and valuation differences on securities contribute to equity and comprehensive-income variability., Margin-normalization risk: the FY plan depends on a 20.0% operating-income increase despite a 1.0% revenue decline, raising the importance of retaining H1 cost and price benefits..

Key concerns include Highest priority is working-capital normalization: slow receivables, elevated inventory days, and a 140-day cash conversion cycle could weaken cash flow if H1 favorable receivables movements reverse., The short-term debt structure is a material risk by maturity profile, though its near-term impact is moderated by 0.96x debt/EBITDA and 93.66x EBITDA interest coverage., The quality alerts are more concerning operationally than solvency-wise: balance-sheet liquidity is adequate, but cash conversion remains structurally inefficient for a manufacturing business., The company remains exposed to cyclical chemical-sector demand, feedstock-cost movements, energy prices, and environmental/regulatory compliance requirements..

Investment Implications

Key takeaways include H1 profitability improved materially despite lower revenue: operating margin reached 14.1% and net margin 9.9%., Earnings are cash-backed, with ¥7.81bn of operating cash flow, a 1.48x OCF/net-income ratio, and ¥4.86bn of free cash flow., The full-year operating-income target appears achievable from a progress perspective, with H1 already at 55.6% of guidance., Balance-sheet leverage is low on reported metrics, but all reported debt is short-term and therefore requires continuing refinancing access., Working-capital efficiency is the central issue, given 108-day DSO, reported inventory-day alerts of 119 and 95 days, and a 140-day cash conversion cycle..

Metrics to watch include Gross margin and operating margin retention versus the H1 levels of 26.4% and 14.1%, Revenue progress toward the ¥114.00bn full-year plan, Receivable days, inventory days, and cash conversion cycle, Short-term debt rollover, cash-to-short-term-debt coverage, and debt/EBITDA, Operating cash flow and free cash flow coverage of the planned ¥130 full-year DPS, Movement in the ¥11.00bn investment-securities portfolio and related OCI.

Regarding relative positioning, The company combines good annualized ROE of 13.6%, a strong 19.7% EBITDA margin, low reported debt/EBITDA of 0.96x, and robust interest coverage, positioning it favorably on profitability and conventional credit metrics. Relative weakness lies in cash-cycle efficiency and funding maturity structure: the 140-day reported cash conversion cycle and 100% short-term reported debt ratio warrant closer monitoring than the headline leverage ratios alone.